TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Mar 31, 2021 14:09 JST
Source:
Toyota Motor Corporation
Toyota: First Refrigerated Vehicle for Vaccine in the World to Obtain WHO's Performance, Quality and Safety Prequalification
Establishing methods for refrigerated vaccine transportation and contributing toward improving the rate of vaccine use in developing countries
Toyota City, Japan, Mar 31, 2021 - (JCN Newswire) - Toyota Tsusho Corporation, Toyota Motor Corporation, and B Medical Systems S.a r.l. announced today that the vehicle with a dedicated refrigerator for transporting vaccines at the appropriate temperatures developed jointly by the three companies has obtained Performance, Quality and Safety (PQS) prequalification for quality of medical devices and equipment as set by the World Health Organization (WHO). The company registered for the prequalification is Toyota Tsusho and this is the first refrigerated vehicle for vaccines in the world that has obtained PQS prequalification.
1. Background
Vaccination is an effective measure against infectious diseases. General mandatory vaccines for infants usually require storage at 2 to 8degC, and cannot be used if not stored under proper temperature management. Although developing countries receive assistance from international agencies such as GAVI, the Vaccine Alliance and UNICEF for the supply of vaccines, approximately 20% of the volume supplied (equivalent to JPY 40 billion per year) are disposed annually because they become unusable due to temperature changes during transportation when distributing to hospitals and clinics within the respective countries, as the road infrastructures are inadequate and there is no proper means for refrigerated transportation. Each year, the lives of 1.5 million children are lost to vaccine preventable diseases (VPD) with insufficient effective utilization of vaccines being one of the reasons.
2. WHO's PQS and Significance of Prequalification
PQS is a system for the qualification of medical devices and equipment by WHO that was established to promote the development of medical devices and equipment applicable for the United Nations' procurement as well as to set quality standards. Medical devices and equipment which have obtained PQS prequalification also meet the equipment selection standards of agencies related to the United Nations and leading NGOs and charity organizations.
Also, it is easier for developing countries without their own qualification system for medical devices and equipment to receive support for transportation equipment procurement by using PQS as the qualification standard, and effective use of vaccines can be expected.
This initiative contributes to the effective use of vaccines, addressing a social issue in developing countries. At the same time, it has the significance of being able to demonstrate initiative in the field of global health transportation. In addition, this refrigerated vehicle for vaccines can now be used under the international framework COVAX, which seeks to distribute vaccines for COVID-19 fairly to developing countries, and its use as a means of transportation for COVID-19 vaccines can also be expected.
3. Overview of Refrigerated Vehicle for Vaccines
The features of the refrigerated vehicle for vaccines which obtained PQS prequalification this time are as follows:
- The base vehicle is Toyota Land Cruiser 78, which is equipped with the B Medical Systems' CF850 vaccine refrigerator.
- The refrigerator has a storage capacity of 396 liters, or 400 vaccine packages.
- With its independent battery, the refrigerator can be operated for approximately 16 hours without a power supply.
- The refrigerator can be charged by the vehicle while driving and from an external power source when parked.
4. Roles of Each Company
1. Toyota Tsusho uses the knowledge and awareness of issues developed through business in Africa to provide the refrigerated vehicle for vaccines as the company obtaining PQS prequalification.
2. Toyota provides the Toyota Land Cruiser 78.
3. B Medical Systems provides the CF850 vaccine refrigerator.
4. Toyota Tsusho Group company CFAO SAS and Toyota Group company TOYOTA CUSTOMIZING & DEVELOPMENT Co., Ltd. conduct vehicle installation and conversion.
"We aim to deliver Safety and Security".
For this project, Toyota Tsusho, Toyota, and B-Medical Systems, have joined forces with the same goal in mind. We will continue to make efforts so that the obtainment of PQS for the refrigerated vehicle for vaccines will contribute to the Safety and Security of the region.
Source: Toyota Motor Corporation
Sectors: Automotive, Motorsports
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Toyota Launches All-New Land Cruiser "250" Series in Japan
April 18 2024 12:39 JST
Lexus presents Time at the 2024 Milan Design Week
April 16 2024 17:49 JST
New circuit challenge for TOYOTA GAZOO Racing
April 15 2024 16:21 JST
TOYOTA GAZOO Racing back on asphalt for Croatian challenge
April 12 2024 18:36 JST
Daihatsu and Toyota to Reform Structures towards the Revitalization of Daihatsu
April 08 2024 12:37 JST
Toyota Completes Toyota Technical Center Shimoyama Research and Development Facility for Making Ever-better Cars
April 02 2024 10:28 JST
TOYOTA GAZOO Racing roars to fourth successive Safari triumph
April 01 2024 09:47 JST
Toyota Releases Sales, Production, and Export Results for February 2024
March 28 2024 12:35 JST
PEVE to change name to TOYOTA BATTERY Co., Ltd. and produce batteries for a wide range of electric vehicles
March 27 2024 14:13 JST
Toyota to Open New Tokyo Head Office in Shinagawa in FY2030
March 22 2024 15:15 JST
More Press release >>
Latest Press Release
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 09:22 JST
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
Apr 17, 2024 16:17 JST
Honda Unveils Next-generation EV Series for China
Apr 17, 2024 12:15 JST
Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST
Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA
Apr 16, 2024 14:36 JST
New circuit challenge for TOYOTA GAZOO Racing
Apr 15, 2024 17:21 JST
TOYOTA GAZOO Racing back on asphalt for Croatian challenge
Apr 12, 2024 19:36 JST
Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project
Apr 12, 2024 14:39 JST
MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors
Apr 11, 2024 18:08 JST
Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS)
Apr 11, 2024 17:50 JST
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 11, 2024 15:10 JST
Mitsubishi Corporation Announces Completion of Capital Raise by Nexamp
Apr 11, 2024 13:07 JST
Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine
Apr 10, 2024 16:55 JST
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 10, 2024 13:36 JST
More Latest Release >>